
PATIENT SUPPORT SERVICES
Access Services by Bayer™ provides several options to help patients access their VITRAKVI® treatment

- Perform benefits investigation to identify patient’s insurance coverage and out-of-pocket expense
- Assistance with prior authorization and appeals
- Provide payer policy information
- Identify and triage prescription to specialty pharmacy covered by patient’s health plan
- VITRAKVI $0 Co-Pay Program for eligible, commercially insured patientsa
- Identify and refer appropriate patients to independent charitable foundations
- Refer eligible patients to the Bayer US Patient Assistance Foundation
- To enroll your patients in Access Services by Bayer, click here
Access Services by Bayer™ provides several options to help patients access their VITRAKVI® treatment
- A dedicated phone line provides patients taking VITRAKVI direct access to a nurse or pharmacist who can answer questions about treatment with VITRAKVI
- These specialists will also triage patients back to their treating oncologist as appropriate
- Regularly scheduled outbound calls to provide information about:
- VITRAKVI treatment
- Understanding dosing recommendations for adult and pediatric patients
- Signing up for optional text message refill reminders
- Verifying or facilitating enrollment in Access Services by Bayer for financial assistance options if eligible
Help connecting with a VITRAKVI designated contracted pharmacy
Accredo®: 1-855-540-1797; www.accredo.com
CVS Specialty™: 1-800-790-1698; www.cvsspecialty.com
aPatients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payers of any benefits they receive and the value of this program, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in the Bayer US Patient Assistance Foundation are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of VITRAKVI $0 Co-pay Program at any time, including but not limited to this commercial co-pay assistance program.